Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 28, 2014 (12 years ago)

Fluocinonide Gel USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15 gram tubes and b) NET WT 60 grams tubes, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0135-15 (15 g) and NDC 0168-0135-60 (60 g)

Affected NDCs 0168-0135-15 0168-0135-60

Compare with the code on your package — it is the most precise check available.

Drug: Fluocinonide Category: Eye Drops & Ophthalmic

Recalling firm
Fougera Pharmaceuticals Inc.
NDC code
0168-0135-15
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0245-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fluocinonide recalls

See all
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-3 D-0477-2026
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-2 D-0476-2026
Class II · Moderate risk

Fluocinonide

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Ongoing Failed specification Sun Pharmaceutical Industries INC NDC 51672-1386-1 D-0475-2026
Class II · Moderate risk

Fluocinonide Topical Solution USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-025-20 D-0685-2022
Class II · Moderate risk

Fluocinonide Gel USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-054-15 D-0684-2022

Other recalls by Fougera Pharmaceuticals Inc.

All 2014 recalls
Class II · Moderate risk

Desonide Ointment

Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream

Terminated Labeling / mix-up Fougera Pharmaceuticals Inc. NDC 0168-0309-60 D-0612-2017
Class III · Low risk

Triamcinolone Acetonide Lotion USP

Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry.

Terminated Failed specification Fougera Pharmaceuticals Inc. NDC 0168-0336-60 D-1441-2014
Class III · Low risk

Triamcinolone Acetonide Lotion USP

Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry.

Terminated Failed specification Fougera Pharmaceuticals Inc. NDC 0168-0337-60 D-1440-2014
Class III · Low risk

Triamcinolone Acetonide Cream USP

Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Terminated Labeling / mix-up Fougera Pharmaceuticals Inc. NDC 0168-0004-80 D-1152-2014